Results 201 to 210 of about 178,253 (288)

Post-acute and long-term cardiovascular effects following dengue infection: A systematic review protocol. [PDF]

PLoS One
Lokunarangoda NC, Wimalasundera AR, Perera MHMTS, Idampitiya D, Perera HNT, Kothalawala KGD, Pathmeswaran A, Liyanage NPM, Wijewickrama A, Medagama UAB.   +9 more
europepmc   +1 more source

Climate Justice and One Health Adaptation Policies in Public Health and Disaster Medicine

Public Health Challenges, Volume 5, Issue 3, September 2026.
ABSTRACT Background Climate change is intensifying public health risks and placing increasing pressure on disaster medicine systems. These challenges require adaptation strategies that incorporate climate justice principles and the One Health framework.
Ioannis Adamopoulos, Aida Vafae Eslahi, Niki Syrou, Konstantina Diamanti, Marilena Katsogiannou, Panagiotis Tsirkas, Maad M. Mijwil, Vesna Tornjanski, Harshit Mishra, Elma Hrustemović, Guma Ali   +10 more
wiley   +1 more source

Epidemiology of Dengue Virus Infection in Different Geopolitical Zones of Odisha in Relation to Climatic Variation: An Observational Study. [PDF]

Indian J Community Med
Panda S, Patra G, Mishra DS, Bindhani BK, Dwibedi B.   +4 more
europepmc   +1 more source

The Changing Landscape of Hantavirus Infections: A Narrative Review of Epidemiology, Pathogenesis, and Countermeasures

Reviews in Medical Virology, Volume 36, Issue 5, September 2026.
ABSTRACT Hantaviruses are emerging zoonotic pathogens of increasing global public health significance. Their epidemiological landscape is rapidly changing due to ecological disruption, climate variability, urbanisation, and evolving human–animal interfaces.
Francesco De Maria, Francesco Branda, Giancarlo Ceccarelli, Fabio Scarpa, Massimo Ciccozzi, Alessandro Russo   +5 more
wiley   +1 more source

Ocular manifestations of expanded dengue syndrome: a systematic review with meta-analysis. [PDF]

Trop Med Health
Peñaherrera-Vásquez D, Fuenmayor-González L, Fierro G, Andrade M JF, Guarderas-Muñoz SJ, Campoverde S, Chuchuca-Carrión G, Rivadeneira J.   +7 more
europepmc   +1 more source

Dengue Virus Molecular Targets and Antiviral Drug Development: Advances, Challenges and Therapeutic Perspectives

ChemistrySelect, Volume 11, Issue 33, 1 September 2026.
This narrative review analyzes DENV molecular targets, including structural proteins (C, prM/M, E), non‐structural components (NS1NS5), and host factors, alongside small‐molecule candidates in preclinical and clinical phases. Owing to high structural conservation, the NS2B‐NS3 protease and NS5 (RdRp/MTase) remain primary drug discovery focuses, while ...
Aryane Lucia da Silva Aguiar De Oliveira, José Arion Da Silva Moura, Pedro César de Souza, Marcelo Arthur Dias da Costa Santana, Matheus Vinicius Guimarães de Melo, Douglas Carvalho Francisco Viana, Marina Galdino Da Rocha Pitta, Isabella Luiza Ralph de Oliveira, Maira Galdino Da Rocha Pitta   +8 more
wiley   +1 more source

Dengue outbreaks in China during 2005-2023: a systematic analysis. [PDF]

Front Cell Infect Microbiol
Peng K, Huang X, Huang P, Zhao H, Pan X, Xu N, Yin H, Yang Y, Han C, Gong M, Liu H.   +10 more
europepmc   +1 more source

Design and Synthesis of a Potent, Cell Active Purine‐Based Amidoxime Against the Dengue Virus

ChemistrySelect, Volume 11, Issue 36, 22 September 2026.
Scaffold hopping from our previous indolazepinone hit exemplifies purine SP‐835G with DENV2 EC50 0.1 µM, CC50>100 µM, clogP 3.61. Docking studies support its amidine metabolite operates as an allosteric inhibitor of DENV(pro). A flexible ether linker appears pivotal for enhancing binding and activity.
Dimitrios Kiousis, Despoina Giannioti, Georgia Kalyva, Vasiliki Zogali, Maharah Binte Abdul Mahid, Kitti Wing Ki Chan, Minos‐Timotheos Matsoukas, Subhash G. Vasudevan, Gerasimos Rassias   +8 more
wiley   +1 more source

Overall and serotype-specific dengue virus transmission intensity in Mexico, 2016-2023: A modelling study of case-notification data. [PDF]

PLoS Med
Simmons OS, Vicco A, Martínez-Vega RA, Ramos-Castañeda J, Dorigatti I.   +4 more
europepmc   +1 more source